IL158691A0 - Solid orally-dispersible pharmaceutical formulation - Google Patents

Solid orally-dispersible pharmaceutical formulation

Info

Publication number
IL158691A0
IL158691A0 IL15869102A IL15869102A IL158691A0 IL 158691 A0 IL158691 A0 IL 158691A0 IL 15869102 A IL15869102 A IL 15869102A IL 15869102 A IL15869102 A IL 15869102A IL 158691 A0 IL158691 A0 IL 158691A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
solid orally
dispersible pharmaceutical
dispersible
orally
Prior art date
Application number
IL15869102A
Other languages
English (en)
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of IL158691A0 publication Critical patent/IL158691A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IL15869102A 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation IL158691A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200647A FR2834889B1 (fr) 2002-01-18 2002-01-18 Forme pharmaceutique solide orodispersible
PCT/FR2002/004454 WO2003061623A1 (fr) 2002-01-18 2002-12-19 Forme pharmaceutique solide orodispersible

Publications (1)

Publication Number Publication Date
IL158691A0 true IL158691A0 (en) 2004-05-12

Family

ID=27589521

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15869102A IL158691A0 (en) 2002-01-18 2002-12-19 Solid orally-dispersible pharmaceutical formulation
IL158691A IL158691A (en) 2002-01-18 2003-10-30 Solid pharmaceutical compositions that are dispersed in the mouth

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158691A IL158691A (en) 2002-01-18 2003-10-30 Solid pharmaceutical compositions that are dispersed in the mouth

Country Status (22)

Country Link
US (1) US7201922B2 (fr)
EP (1) EP1465593B1 (fr)
JP (1) JP2005515240A (fr)
KR (1) KR100961367B1 (fr)
CN (1) CN1248681C (fr)
AT (1) ATE439828T1 (fr)
AU (1) AU2002364468C1 (fr)
BR (1) BR0208161A (fr)
CA (1) CA2441796A1 (fr)
CZ (1) CZ20032486A3 (fr)
DE (1) DE60233436D1 (fr)
FR (1) FR2834889B1 (fr)
HU (1) HUP0303948A2 (fr)
IL (2) IL158691A0 (fr)
MX (1) MXPA03008420A (fr)
NO (1) NO326259B1 (fr)
NZ (1) NZ529694A (fr)
PL (1) PL209144B1 (fr)
RU (1) RU2317812C2 (fr)
SK (1) SK287812B6 (fr)
WO (1) WO2003061623A1 (fr)
ZA (1) ZA200308664B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024380A1 (fr) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticules contenant du peg et/ou des esters glyceriliques de peg
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
DE10229472A1 (de) * 2002-07-01 2004-01-15 Symrise Gmbh & Co. Kg Kompaktierter Milchsäurementhylester
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
KR101109633B1 (ko) 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
FR2920311B1 (fr) * 2007-08-31 2010-06-18 Galenix Innovations Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
JP5637624B2 (ja) * 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
RU2497505C1 (ru) * 2012-11-07 2013-11-10 Максим Эдуардович Запольский Новая лекарственная композиция для лечения болевого синдрома при спазме гладкой мускулатуры
RU2503447C1 (ru) * 2012-11-20 2014-01-10 Максим Эдуардович Запольский Лекарственное средство в форме ородисперсной таблетки и способ получения лекарственного средства
KR20160030093A (ko) * 2013-07-19 2016-03-16 가부시키가이샤산와카가쿠켄큐쇼 구강 내 붕괴정
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
WO2019146642A1 (fr) * 2018-01-24 2019-08-01 大原薬品工業株式会社 MÉTHODE D'AMÉLIORATION DE LA STABILITÉ CHIMIQUE D'UN COMPRIMÉ CONTENANT UN DÉRIVÉ D'ACIDE γ-AMINOBUTYRIQUE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
PT922464E (pt) * 1996-07-12 2005-07-29 Daiichi Seiyaku Co Materiais moldados por compressao rapidamente desintegraveis e processo para a sua producao
FR2752162B1 (fr) 1996-08-07 1998-11-06 Jouveinal Lab Comprime de maleate de trimebutine pellicule
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
AU3574500A (en) 1999-03-25 2000-10-16 Yuhan Corporation Rapidly disintegrable tablet for oral administration
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
JP4446463B2 (ja) * 2000-10-16 2010-04-07 第一三共株式会社 口腔内速崩壊性医薬組成物およびその製造方法
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
BR0215193A (pt) * 2001-12-21 2004-11-16 Pfizer Prod Inc Formulações de azitromicina diretamente compressìveis
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
EP1487419A2 (fr) * 2002-03-20 2004-12-22 Elan Pharma International Limited Formes posologiques a dissolution rapide presentant une friabilite reduite

Also Published As

Publication number Publication date
HU0303948D0 (en) 2004-01-28
JP2005515240A (ja) 2005-05-26
CN1516576A (zh) 2004-07-28
CN1248681C (zh) 2006-04-05
NO20034139D0 (no) 2003-09-17
WO2003061623A1 (fr) 2003-07-31
DE60233436D1 (de) 2009-10-01
PL362762A1 (en) 2004-11-02
FR2834889B1 (fr) 2004-04-02
KR100961367B1 (ko) 2010-06-07
US7201922B2 (en) 2007-04-10
KR20040073288A (ko) 2004-08-19
US20030147947A1 (en) 2003-08-07
MXPA03008420A (es) 2004-03-16
AU2002364468B2 (en) 2008-06-26
RU2003128025A (ru) 2005-03-27
NO326259B1 (no) 2008-10-27
NZ529694A (en) 2006-04-28
EP1465593B1 (fr) 2009-08-19
AU2002364468C1 (en) 2009-01-22
IL158691A (en) 2008-08-07
ZA200308664B (en) 2004-11-08
NO20034139L (no) 2003-11-11
PL209144B1 (pl) 2011-07-29
HUP0303948A2 (hu) 2004-04-28
EP1465593A1 (fr) 2004-10-13
BR0208161A (pt) 2004-03-02
SK11712003A3 (sk) 2004-02-03
SK287812B6 (sk) 2011-10-04
RU2317812C2 (ru) 2008-02-27
CA2441796A1 (fr) 2003-07-31
ATE439828T1 (de) 2009-09-15
FR2834889A1 (fr) 2003-07-25
CZ20032486A3 (cs) 2004-01-14

Similar Documents

Publication Publication Date Title
HU0303948D0 (en) Solid orally-dispersible pharmaceutical formulation
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
IL174863A0 (en) Compounds that inhibit serine proteases and pharmaceutical compositions containing the same
HK1076742A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
IL175210A0 (en) Non-pancreatic proteases and pharmaceutical compositions containing the same
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
DE60029956D1 (de) Amid-substituierte Imidazochinoline
IL171285A (en) Pharmaceuticals containing interleukin-6 antagonist and their uses
IL170454A (en) Preparations of active ingredients for administration through the skin or through mucous membranes and their uses
MY157827A (en) Sulfonamide substituted imidazoquinolines
HRP20041152B1 (en) Pharmaceutical formulations
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL169793A (en) Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product
WO2003103571A3 (fr) Vaccins contre les flavivirus
TW200602062A (en) Improved formulations of 6-mercaptopurine
IL164217A0 (en) Pharmaceutical compositions containing water-soluble propofol and methods of administering same
IL173929A (en) Kahlalid F analogs and their pharmacy preparations
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
HUP0600778A3 (en) Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
WO2005030142A3 (fr) Formulations de rifalazil
HK1094152A1 (en) Orodispersible pharmaceutical composition of an antithrombotic compound
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
WO2006044548A3 (fr) Compositions contenant du clopidogrel
EP1461450A4 (fr) Compositions t-bet et methodes d'utilisation associees
AU2003291757A8 (en) Formulations of low solubility bioactive agents and processes for making the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed